← All stories
Markets
Is Ananda (LSE:ANA) Now Carrying London's Cannabinoid Medicine Hopes Alone?
Highlights Ananda Developments has registered its lead cannabidiol candidate on a public clinical trials database. Later-stage clinical activity is being routed through Australia to access research incentives. The company has emerged as Lon…
Covered by 1 outlet
All coverage · 1 article